ConvaTec Group agrees to acquire Triad Life Sciences

LONDON, UK: ConvaTec Group has entered into a definitive agreement to acquire Triad Life Sciences Inc, a US-focused medical device company that develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. The initial consideration is $125 million with two potential additional payments of $25 million each relating to…

ConvaTec Group plc

ConvaTec Group plc is an international medical products and technologies company, offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Type:                     Public limited company Traded…